Related Experiment Video
Updated: May 27, 2026

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
Published on: September 9, 2021
Homogeneous single-label biochemical Ras activation assay using time-resolved luminescence
Abstract:
Mutations of the small GTP-binding protein Ras have been commonly found in tumors, and Ras oncogenes have been established to be involved in the early steps of cancerogenesis. The detection of Ras activity is critical in the determination of the cell signaling events controlling cell growth and differentiation. Therefore, development of improved methods for primary screening of novel potential drugs that target small GTPase or their regulators and their signaling pathways is important. Several assays have been developed for small GTPases studies, but all these methods have limitations for a high-throughput screening (HTS) use. Multiple steps including separation, use of radioactive labels or time-consuming immunoblotting, and a need of large quantities of purified proteins are decreasing the user-friendliness of these methods. Here, we have developed a homogeneous H-Ras activity assay based on a single-label utilizing the homogeneous quenching resonance energy transfer technique (QRET). In the QRET method, the binding of a terbium-labeled GTP (Tb-GTP) to small GTPase protein H-Ras protects the signal of the label from quenching, whereas the signal of the nonbound fraction of Tb-GTP is quenched by a soluble quencher. This enables a rapid determination of the changes in the activity status of Ras. The assay optimization showed that only 60 nM concentration of purified H-Ras protein was needed. The functionality of the assay was proved by detecting the effect of H-Ras guanine nucleotide exchange factor, Son of Sevenless. The signal-to-background ratio up to 7.7 was achieved with an average assay coefficient of variation of 9.1%. The use of a low concentration of purified protein is desirable and the signal-to-background ratio of 3.4 was achieved in the assay at a concentration of 60 nM for H-Ras and SOS proteins. The need of only one labeled molecule and the ability to decrease the quantities of purified proteins used in the experiments are valuable qualities in HTS showing the potential of the QRET method.
Insights
Researchers developed a new homogeneous assay to detect Ras protein activity, crucial for cancer research. This method uses a single label and reduces protein quantity, making it ideal for high-throughput screening of potential cancer drugs.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Ras GTP-binding proteins are frequently mutated in tumors and play a key role in cancer development.
- Detecting Ras activity is vital for understanding cell signaling in growth and differentiation, and for developing targeted cancer therapies.
- Existing assays for small GTPases have limitations for high-throughput screening (HTS), including multiple steps, radioactive labels, and high protein requirements.
Discussion:
- A novel homogeneous H-Ras activity assay was developed using homogeneous quenching resonance energy transfer (QRET).
- The QRET assay utilizes a single terbium-labeled GTP (Tb-GTP) and a soluble quencher to measure Ras activity.
- This method allows rapid determination of Ras activity status by monitoring the protection of Tb-GTP signal upon binding to H-Ras.
Key Insights:
- The assay requires only 60 nM of purified H-Ras protein, significantly reducing protein quantity.
- Functionality was validated by detecting the effect of Son of Sevenless (SOS), a Ras guanine nucleotide exchange factor.
- High signal-to-background ratios (up to 7.7) and low coefficient of variation (9.1%) were achieved, demonstrating assay robustness.
Outlook:
- The QRET assay's efficiency and low protein requirement make it highly suitable for HTS applications.
- This method holds potential for accelerating the discovery of novel drugs targeting small GTPases and their pathways.
- Further optimization could enhance its utility in drug discovery pipelines for various cancers.

